Berenyiova, A.;                     Bernatova, I.;                     Zemancikova, A.;                     Drobna, M.;                     Cebova, M.;                     Golas, S.;                     Balis, P.;                     Liskova, S.;                     Valaskova, Z.;                     Krskova, K.;     
    et al.    Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension? Biomedicines 2022, 10, 38.
    https://doi.org/10.3390/biomedicines10010038
    AMA Style
    
                                Berenyiova A,                                 Bernatova I,                                 Zemancikova A,                                 Drobna M,                                 Cebova M,                                 Golas S,                                 Balis P,                                 Liskova S,                                 Valaskova Z,                                 Krskova K,         
        et al.        Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension? Biomedicines. 2022; 10(1):38.
        https://doi.org/10.3390/biomedicines10010038
    
    Chicago/Turabian Style
    
                                Berenyiova, Andrea,                                 Iveta Bernatova,                                 Anna Zemancikova,                                 Magdalena Drobna,                                 Martina Cebova,                                 Samuel Golas,                                 Peter Balis,                                 Silvia Liskova,                                 Zuzana Valaskova,                                 Katarina Krskova,         
         and et al.        2022. "Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension?" Biomedicines 10, no. 1: 38.
        https://doi.org/10.3390/biomedicines10010038
    
    APA Style
    
                                Berenyiova, A.,                                 Bernatova, I.,                                 Zemancikova, A.,                                 Drobna, M.,                                 Cebova, M.,                                 Golas, S.,                                 Balis, P.,                                 Liskova, S.,                                 Valaskova, Z.,                                 Krskova, K.,                                 Zorad, S.,                                 Dayar, E.,                                 & Cacanyiova, S.        
        
        (2022). Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension? Biomedicines, 10(1), 38.
        https://doi.org/10.3390/biomedicines10010038